ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MIST Milestone Pharmaceuticals Inc

1.39
0.00 (0.00%)
19 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Milestone Pharmaceuticals Inc MIST NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.39 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.39 1.37 1.44 1.39 1.39
more quote information »

Recent News

Date Time Source Heading
29/5/202421:09EDGAR2Form 8-K - Current report
22/5/202422:00GLOBEMilestone Pharmaceuticals Partners with Arrhythmia Alliance..
13/5/202421:34EDGAR2Form 8-K - Current report
13/5/202420:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/3/202401:00EDGAR2Form 8-K - Current report
02/3/202408:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202423:00GLOBEMilestone Pharmaceuticals Announces Pricing of $30.0 Million..
29/2/202408:37GLOBEMilestone Pharmaceuticals Announces Proposed Public Offering..
26/2/202423:06EDGAR2Form 8-K - Current report
15/2/202412:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202423:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/12/202300:54DJNMilestone Pharmaceuticals Shares Sink 24% After Receiving..
26/12/202323:57DJNMilestone Pharmaceuticals' Etripamil Nasal Spray Application..
26/12/202323:15EDGAR2Form 8-K - Current report
21/11/202323:00PRNCAMilestone Pharmaceuticals to Present at the Piper Sandler..
13/11/202323:05EDGAR2Form 8-K - Current report
13/11/202322:57PRNUSMilestone Pharmaceuticals Reports Third Quarter 2023..
13/11/202322:37EDGAR2Form 8-K - Current report
13/11/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202302:00PRNUSMilestone Pharmaceuticals Presents Positive Results from..
10/11/202308:43EDGAR2Form SC 13D - General statement of acquisition of beneficial..
08/11/202301:07EDGAR2Form 8-K - Current report
07/11/202323:00PRNUSMilestone Pharmaceuticals to Host Investor and Analyst..
25/10/202307:05EDGAR2Form 8-K - Current report
24/10/202322:00PRNCAMilestone Pharmaceuticals Announces Submission of New Drug..
06/10/202322:00PRNUSMilestone Pharmaceuticals Reports Inducement Grants Under..
27/9/202321:00PRNCAMilestone Pharmaceuticals Announces Etripamil AFib-RVR Study..
05/9/202321:00PRNCAMilestone Pharmaceuticals to Present at the H.C. Wainwright..
10/8/202321:40EDGAR2Form 8-K - Current report
10/8/202321:35PRNCAMilestone Pharmaceuticals Reports Second Quarter 2023..
10/8/202321:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/6/202321:00PRNUSMilestone Pharmaceuticals Announces Publication of Results..

Your Recent History

Delayed Upgrade Clock